Implementation of an Outpatient Parenteral Antimicrobial Therapy Program

Outpatient Clinical Trial

Official title: Implementation of an Outpatient Parenteral Antimicrobial Therapy Program

Status Recruiting

Clinical Trial Summary

To determine cost changes with an Outpatient Parenteral Antimicrobial Therapy Program (OPAT) treatment compared to standard therapy while maintaining safety and efficacy.

Clinical Trial Description

Patients will be evaluated during the period January 2023 to January 2024. Patients over 18 years admitted to the University Hospital Dr. José Eleuterio González with microbiological diagnosis of an infection that needs an intravenous antimicrobial treatment for more than three days, without other criteria to remain hospitalized. Informed consent will be provided to the patient, which is a requirement to enter the study, on it we will explain in detail the processes and follow-ups that you will have during participation in the study, as well as the confidentiality of personal data and results. After signing informed consent, patients will be randomized 1:1 to enter the OPAT group or the inpatient antimicrobial therapy group. Subjects will be stratified according to the diagnosed infection and will be followed within the protocol up to 30 after the end of the antimicrobial treatment established by the physician. ;

Related Conditions & MeSH terms

• Outpatient

• NCT number: NCT05707507
• Study type: Interventional
• Source: Hospital Universitario Dr. Jose E. Gonzalez
• Contact: Adrian Camacho Ortiz, PhD
• Phone: 81230812
• Email: acamacho_md@yahoo.com
• Status: Recruiting
• Phase: N/A
• Start date: February 1, 2023
• Completion date: January 10, 2024